Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons

Title
Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
Authors
Keywords
Alzheimer’s disease, induced pluripotent stem cells, disease modeling, drug screening, lipids, cholesterol metabolism, cholesteryl esters, CYP46A1 Tau, amyloid beta, proteostasis
Journal
Cell Stem Cell
Volume 24, Issue 3, Pages 363-375.e9
Publisher
Elsevier BV
Online
2019-01-27
DOI
10.1016/j.stem.2018.12.013

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started